{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T11:26:08Z","timestamp":1770463568352,"version":"3.49.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Inherited myopathies are genetic disorders characterised by declining motor function due to progressive muscle weakening and wasting. Recently, pathogenic variants in\n                    <jats:italic>PAX7<\/jats:italic>\n                    , the master transcriptional regulator of muscle stem cells, have been associated with myopathies of variable severity, arguing for impaired satellite cell function as the main pathogenic driver. Here, we report the characterisation of two missense\n                    <jats:italic>PAX7<\/jats:italic>\n                    variants in a patient with asymmetric, progressive muscle weakness affecting facial, upper and lower body muscles, and myopathic changes on muscle pathology. Despite this disorder closely phenocopying the clinical presentation of Facioscapulohumeral muscular dystrophy (FSHD), genetic, epigenetic and transcriptomic profiling indicated that FSHD was unlikely. However, exome sequencing revealed two heterozygous variants in\n                    <jats:italic>PAX7<\/jats:italic>\n                    : c.335\u2009C\u2009&gt;\u2009T, (p.Pro112Leu) and c.1328\u2009G\u2009&gt;\u2009A (p.Cys443Tyr). Modelling these\n                    <jats:italic>PAX7<\/jats:italic>\n                    variants in human myoblasts resembled the transcriptomic findings found in the muscle biopsy from the patient. Specifically, these\n                    <jats:italic>PAX7<\/jats:italic>\n                    variants caused upregulation of splicing factors, an increase in mitochondrial reactive oxygen species levels and reduced cell proliferation. The phenotypic cell changes caused by the PAX7 variants support a pathomechanism whereby diminished satellite cell function impairs muscle homoeostasis. Together, multimodal investigation suggests that these variants in\n                    <jats:italic>PAX7<\/jats:italic>\n                    are likely causative of an FSHD-like autosomal recessive myopathy and expand the spectrum of neuromuscular disorders originating from impaired satellite cell function.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-08358-6","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T21:52:42Z","timestamp":1769723562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biallelic PAX7 variants cause a novel Satellite Cell-opathy with progressive muscle involvement resembling facioscapulohumeral muscular dystrophy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3163-9707","authenticated-orcid":false,"given":"Massimo","family":"Ganassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Strafella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Savarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Heher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise N.","family":"Engquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3549-558X","authenticated-orcid":false,"given":"Mridul","family":"Johari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-9452","authenticated-orcid":false,"given":"Gian F.","family":"De Nicola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0337-5425","authenticated-orcid":false,"given":"Anne","family":"Bigot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Mouly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Bortolani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Torchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Monforte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenica","family":"Megalizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sabino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzo","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliano","family":"Giardina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter S.","family":"Zammit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0849-9144","authenticated-orcid":false,"given":"Giorgio","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"8358_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1152\/jappl.2000.89.1.81","volume":"89","author":"I Janssen","year":"2000","unstructured":"Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985). 2000;89:81\u20138.","journal-title":"J Appl Physiol (1985)"},{"key":"8358_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118742","volume":"1867","author":"SI Fukada","year":"2020","unstructured":"Fukada SI, Akimoto T, Sotiropoulos A. Role of damage and management in muscle hypertrophy: Different behaviors of muscle stem cells in regeneration and hypertrophy. Biochim Biophys Acta Mol Cell Res. 2020;1867:118742.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"8358_CR3","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1242\/dev.069088","volume":"139","author":"F Relaix","year":"2012","unstructured":"Relaix F, Zammit PS. Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development. 2012;139:2845\u201356.","journal-title":"Development"},{"key":"8358_CR4","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","volume":"394","author":"E Mercuri","year":"2019","unstructured":"Mercuri E, Bonnemann CG, Muntoni F. Muscular dystrophies. Lancet. 2019;394:2025\u201338.","journal-title":"Lancet"},{"key":"8358_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2024.105261","volume":"46","author":"L Benarroch","year":"2024","unstructured":"Benarroch L, Bonne G, Rivier F, Procaccio V, Hamroun D. The 2025 version of the gene table of neuromuscular disorders (nuclear genome). Neuromuscul Disord. 2024;46:105261.","journal-title":"Neuromuscul Disord"},{"key":"8358_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.spen.2019.01.005","volume":"29","author":"K Pelin","year":"2019","unstructured":"Pelin K, Wallgren-Pettersson C. Update on the genetics of congenital myopathies. Semin Pediatr Neurol. 2019;29:12\u201322.","journal-title":"Semin Pediatr Neurol"},{"key":"8358_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1055\/s-2008-1062269","volume":"28","author":"M Cardamone","year":"2008","unstructured":"Cardamone M, Darras BT, Ryan MM. Inherited myopathies and muscular dystrophies. Semin Neurol. 2008;28:250\u20139.","journal-title":"Semin Neurol"},{"key":"8358_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112906","volume":"411","author":"M Ganassi","year":"2022","unstructured":"Ganassi M, Muntoni F, Zammit PS. Defining and identifying satellite cell-opathies within muscular dystrophies and myopathies. Exp Cell Res. 2022;411:112906.","journal-title":"Exp Cell Res"},{"key":"8358_CR9","doi-asserted-by":"crossref","unstructured":"Ganassi M, Zammit PS. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: expanding the portfolio of satellite cell-opathies. Eur J Transl Myol. 2022;32:10064.","DOI":"10.4081\/ejtm.2022.10064"},{"key":"8358_CR10","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1038\/s41436-019-0532-z","volume":"21","author":"RG Feichtinger","year":"2019","unstructured":"Feichtinger RG, Mucha BE, Hengel H, Orfi Z, Makowski C, Dort J, et al. Biallelic variants in the transcription factor PAX7 are a new genetic cause of myopathy. Genet Med. 2019;21:2521\u201331.","journal-title":"Genet Med"},{"key":"8358_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13650-z","volume":"10","author":"A Marg","year":"2019","unstructured":"Marg A, Escobar H, Karaiskos N, Grunwald SA, Metzler E, Kieshauer J, et al. Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7. Nat Commun. 2019;10:5776.","journal-title":"Nat Commun"},{"key":"8358_CR12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/cge.13726","volume":"97","author":"A Greco","year":"2020","unstructured":"Greco A, Goossens R, van Engelen B, van der Maarel SM. Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy. Clin Genet. 2020;97:799\u2013814.","journal-title":"Clin Genet"},{"key":"8358_CR13","unstructured":"Padberg GWAM Facioscapulohumeral disease. https:\/\/scholarlypublications.universiteitleiden.nl\/handle\/1887\/25818"},{"key":"8358_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41582-022-00762-2","volume":"19","author":"MS Tihaya","year":"2023","unstructured":"Tihaya MS, Mul K, Balog J, de Greef JC, Tapscott SJ, Tawil R, et al. Facioscapulohumeral muscular dystrophy: the road to targeted therapies. Nat Rev Neurol. 2023;19:91\u2013108.","journal-title":"Nat Rev Neurol"},{"key":"8358_CR15","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/hmg\/2.12.2037","volume":"2","author":"JC van Deutekom","year":"1993","unstructured":"van Deutekom JC, Wijmenga C, van Tienhoven EA, Gruter AM, Hewitt JE, Padberg GW, et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet. 1993;2:2037\u201342.","journal-title":"Hum Mol Genet"},{"key":"8358_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/ng1262","volume":"35","author":"PG van Overveld","year":"2003","unstructured":"van Overveld PG, Lemmers RJ, Sandkuijl LA, Enthoven L, Winokur ST, Bakels F, et al. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet. 2003;35:315\u20137.","journal-title":"Nat Genet"},{"key":"8358_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/ng0992-26","volume":"2","author":"C Wijmenga","year":"1992","unstructured":"Wijmenga C, Hewitt JE, Sandkuijl LA, Clark LN, Wright TJ, Dauwerse HG, et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet. 1992;2:26\u201330.","journal-title":"Nat Genet"},{"key":"8358_CR18","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/hmg\/3.8.1287","volume":"3","author":"JE Hewitt","year":"1994","unstructured":"Hewitt JE, Lyle R, Clark LN, Valleley EM, Wright TJ, Wijmenga C, et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet. 1994;3:1287\u201395.","journal-title":"Hum Mol Genet"},{"key":"8358_CR19","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ng.2454","volume":"44","author":"RJ Lemmers","year":"2012","unstructured":"Lemmers RJ, Tawil R, Petek LM, Balog J, Block GJ, Santen GW, et al. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet. 2012;44:1370\u20134.","journal-title":"Nat Genet"},{"key":"8358_CR20","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","volume":"98","author":"ML van den Boogaard","year":"2016","unstructured":"van den Boogaard ML, Lemmers R, Balog J, Wohlgemuth M, Auranen M, Mitsuhashi S, et al. Mutations in DNMT3B modify epigenetic repression of the D4Z4 repeat and the penetrance of facioscapulohumeral dystrophy. Am J Hum Genet. 2016;98:1020\u20139.","journal-title":"Am J Hum Genet"},{"key":"8358_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn7732","volume":"10","author":"E Engal","year":"2024","unstructured":"Engal E, Sharma A, Aviel U, Taqatqa N, Juster S, Jaffe-Herman S, et al. DNMT3B splicing dysregulation mediated by SMCHD1 loss contributes to DUX4 overexpression and FSHD pathogenesis. Sci Adv. 2024;10:eadn7732.","journal-title":"Sci Adv"},{"key":"8358_CR22","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/hmg\/ddz239","volume":"28","author":"C Strafella","year":"2019","unstructured":"Strafella C, Caputo V, Galota RM, Campoli G, Bax C, Colantoni L, et al. The variability of SMCHD1 gene in FSHD patients: evidence of new mutations. Hum Mol Genet. 2019;28:3912\u201320.","journal-title":"Hum Mol Genet"},{"key":"8358_CR23","doi-asserted-by":"publisher","first-page":"18157","DOI":"10.1073\/pnas.0708659104","volume":"104","author":"M Dixit","year":"2007","unstructured":"Dixit M, Ansseau E, Tassin A, Winokur S, Shi R, Qian H, et al. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci USA. 2007;104:18157\u201362.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8358_CR24","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1189044","volume":"329","author":"RJ Lemmers","year":"2010","unstructured":"Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Camano P, Dauwerse JG, et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science. 2010;329:1650\u20133.","journal-title":"Science"},{"key":"8358_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.nmd.2022.10.005","volume":"33","author":"M Monforte","year":"2023","unstructured":"Monforte M, Attarian S, Vissing J, Diaz-Manera J, Tasca G. th Ewp. 265th ENMC International Workshop: Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22-24 April 2022, Hoofddorp, The Netherlands. Neuromuscul Disord. 2023;33:65\u201375.","journal-title":"Neuromuscul Disord"},{"key":"8358_CR26","doi-asserted-by":"publisher","first-page":"e38779","DOI":"10.1371\/journal.pone.0038779","volume":"7","author":"G Tasca","year":"2012","unstructured":"Tasca G, Pescatori M, Monforte M, Mirabella M, Iannaccone E, Frusciante R, et al. Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles. PLoS One. 2012;7:e38779.","journal-title":"PLoS One"},{"key":"8358_CR27","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013695","volume":"13","author":"CRS Banerji","year":"2021","unstructured":"Banerji CRS, Zammit PS. Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7. EMBO Mol Med. 2021;13:e13695.","journal-title":"EMBO Mol Med"},{"key":"8358_CR28","doi-asserted-by":"crossref","unstructured":"Lim KRQ, Nguyen Q, Yokota T. DUX4 signalling in the pathogenesis of facioscapulohumeral muscular dystrophy. Int J Mol Sci. 2020;21:729.","DOI":"10.3390\/ijms21030729"},{"key":"8358_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.802573","volume":"10","author":"M Ganassi","year":"2022","unstructured":"Ganassi M, Figeac N, Reynaud M, Ortuste Quiroga HP, Zammit PS. Antagonism Between DUX4 and DUX4c Highlights a Pathomechanism Operating Through beta-Catenin in Facioscapulohumeral Muscular Dystrophy. Front Cell Dev Biol. 2022;10:802573.","journal-title":"Front Cell Dev Biol"},{"key":"8358_CR30","doi-asserted-by":"crossref","unstructured":"Cowley MV, Pruller J, Ganassi M, Zammit PS, Banerji CRS. An in silico FSHD muscle fiber for modeling DUX4 dynamics and predicting the impact of therapy. Elife. 2023;12:e88345.","DOI":"10.7554\/eLife.88345"},{"key":"8358_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01200-4","volume":"8","author":"CRS Banerji","year":"2017","unstructured":"Banerji CRS, Panamarova M, Hebaishi H, White RB, Relaix F, Severini S, et al. PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle. Nat Commun. 2017;8:2152.","journal-title":"Nat Commun"},{"key":"8358_CR32","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/hmg\/ddz043","volume":"28","author":"CRS Banerji","year":"2019","unstructured":"Banerji CRS, Zammit PS. PAX7 target gene repression is a superior FSHD biomarker than DUX4 target gene activation, associating with pathological severity and identifying FSHD at the single-cell level. Hum Mol Genet. 2019;28:2224\u201336.","journal-title":"Hum Mol Genet"},{"key":"8358_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad221","volume":"5","author":"CRS Banerji","year":"2023","unstructured":"Banerji CRS, Greco A, Joosten LAB, van Engelen BGM, Zammit PS. The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy. Brain Commun. 2023;5:fcad221.","journal-title":"Brain Commun"},{"key":"8358_CR34","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1242\/jcs.205427","volume":"130","author":"D Bosnakovski","year":"2017","unstructured":"Bosnakovski D, Toso EA, Hartweck LM, Magli A, Lee HA, Thompson ER, et al. The DUX4 homeodomains mediate inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain. J Cell Sci. 2017;130:3685\u201397.","journal-title":"J Cell Sci"},{"key":"8358_CR35","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/hmg\/ddaa164","volume":"29","author":"CRS Banerji","year":"2020","unstructured":"Banerji CRS, Henderson D, Tawil RN, Zammit PS. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity. Hum Mol Genet. 2020;29:2746\u201360.","journal-title":"Hum Mol Genet"},{"key":"8358_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109947","volume":"27","author":"EN Engquist","year":"2024","unstructured":"Engquist EN, Greco A, Joosten LAB, van Engelen BGM, Banerji CRS, Zammit PS. Transcriptomic gene signatures measure satellite cell activity in muscular dystrophies. iScience. 2024;27:109947.","journal-title":"iScience"},{"key":"8358_CR37","doi-asserted-by":"publisher","first-page":"e100292","DOI":"10.1371\/journal.pone.0100292","volume":"9","author":"G Tasca","year":"2014","unstructured":"Tasca G, Monforte M, Iannaccone E, Laschena F, Ottaviani P, Leoncini E, et al. Upper girdle imaging in facioscapulohumeral muscular dystrophy. PLoS One. 2014;9:e100292.","journal-title":"PLoS One"},{"key":"8358_CR38","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ana.24640","volume":"79","author":"G Tasca","year":"2016","unstructured":"Tasca G, Monforte M, Ottaviani P, Pelliccioni M, Frusciante R, Laschena F, et al. Magnetic resonance imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: Pattern refinement and implications for clinical trials. Ann Neurol. 2016;79:854\u201364.","journal-title":"Ann Neurol"},{"key":"8358_CR39","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s00415-021-10786-1","volume":"269","author":"M Monforte","year":"2022","unstructured":"Monforte M, Bortolani S, Torchia E, Cristiano L, Laschena F, Tartaglione T, et al. Diagnostic magnetic resonance imaging biomarkers for facioscapulohumeral muscular dystrophy identified by machine learning. J Neurol. 2022;269:2055\u201363.","journal-title":"J Neurol"},{"key":"8358_CR40","doi-asserted-by":"crossref","unstructured":"Caputo V, Megalizzi D, Fabrizio C, Termine A, Colantoni L, Bax C, et al. D4Z4 methylation levels combined with a machine learning pipeline highlight single CpG sites as discriminating biomarkers for FSHD patients. Cells. 2022;11:4114.","DOI":"10.3390\/cells11244114"},{"key":"8358_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1101\/gr.160325.113","volume":"24","author":"PN Robinson","year":"2014","unstructured":"Robinson PN, Kohler S, Oellrich A, Sanger Mouse Genetics P, Wang K, Mungall CJ, et al. Improved exome prioritization of disease genes through cross-species phenotype comparison. Genome Res. 2014;24:340\u20138.","journal-title":"Genome Res"},{"key":"8358_CR42","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99:877\u201385.","journal-title":"Am J Hum Genet"},{"key":"8358_CR43","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1093\/nar\/22.22.4574","volume":"22","author":"BW Schafer","year":"1994","unstructured":"Schafer BW, Czerny T, Bernasconi M, Genini M, Busslinger M. Molecular cloning and characterization of a human PAX-7 cDNA expressed in normal and neoplastic myocytes. Nucleic Acids Res. 1994;22:4574\u201382.","journal-title":"Nucleic Acids Res"},{"key":"8358_CR44","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.devcel.2012.03.014","volume":"22","author":"VD Soleimani","year":"2012","unstructured":"Soleimani VD, Punch VG, Kawabe Y, Jones AE, Palidwor GA, Porter CJ, et al. Transcriptional dominance of Pax7 in adult myogenesis is due to high-affinity recognition of homeodomain motifs. Dev Cell. 2012;22:1208\u201320.","journal-title":"Dev Cell"},{"key":"8358_CR45","doi-asserted-by":"publisher","first-page":"7254","DOI":"10.1093\/nar\/gkad520","volume":"51","author":"V Bascunana","year":"2023","unstructured":"Bascunana V, Pelletier A, Gouhier A, Bemmo A, Balsalobre A, Drouin J. Chromatin opening ability of pioneer factor Pax7 depends on unique isoform and C-terminal domain. Nucleic Acids Res. 2023;51:7254\u201368.","journal-title":"Nucleic Acids Res"},{"key":"8358_CR46","doi-asserted-by":"publisher","first-page":"7424","DOI":"10.1093\/nar\/gkab561","volume":"49","author":"A Pelletier","year":"2021","unstructured":"Pelletier A, Mayran A, Gouhier A, Omichinski JG, Balsalobre A, Drouin J. Pax7 pioneer factor action requires both paired and homeo DNA binding domains. Nucleic Acids Res. 2021;49:7424\u201336.","journal-title":"Nucleic Acids Res"},{"key":"8358_CR47","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ydbio.2004.08.015","volume":"275","author":"HC Olguin","year":"2004","unstructured":"Olguin HC, Olwin BB. Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal. Dev Biol. 2004;275:375\u201388.","journal-title":"Dev Biol"},{"key":"8358_CR48","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1083\/jcb.200608122","volume":"177","author":"HC Olguin","year":"2007","unstructured":"Olguin HC, Yang Z, Tapscott SJ, Olwin BB. Reciprocal inhibition between Pax7 and muscle regulatory factors modulates myogenic cell fate determination. J Cell Biol. 2007;177:769\u201379.","journal-title":"J Cell Biol"},{"key":"8358_CR49","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1242\/jcs.02908","volume":"119","author":"PS Zammit","year":"2006","unstructured":"Zammit PS, Relaix F, Nagata Y, Ruiz AP, Collins CA, Partridge TA, et al. Pax7 and myogenic progression in skeletal muscle satellite cells. J Cell Sci. 2006;119:1824\u201332.","journal-title":"J Cell Sci"},{"key":"8358_CR50","doi-asserted-by":"publisher","first-page":"e4475","DOI":"10.1371\/journal.pone.0004475","volume":"4","author":"CA Collins","year":"2009","unstructured":"Collins CA, Gnocchi VF, White RB, Boldrin L, Perez-Ruiz A, Relaix F, et al. Integrated functions of Pax3 and Pax7 in the regulation of proliferation, cell size and myogenic differentiation. PLoS One. 2009;4:e4475.","journal-title":"PLoS One"},{"key":"8358_CR51","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1080\/15384101.2015.1026519","volume":"14","author":"S Badodi","year":"2015","unstructured":"Badodi S, Baruffaldi F, Ganassi M, Battini R, Molinari S. Phosphorylation-dependent degradation of MEF2C contributes to regulate G2\/M transition. Cell Cycle. 2015;14:1517\u201328.","journal-title":"Cell Cycle"},{"key":"8358_CR52","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.bbagrm.2014.05.003","volume":"1839","author":"M Ganassi","year":"2014","unstructured":"Ganassi M, Badodi S, Polacchini A, Baruffaldi F, Battini R, Hughes SM, et al. Distinct functions of alternatively spliced isoforms encoded by zebrafish mef2ca and mef2cb. Biochim Biophys Acta. 2014;1839:559\u201370.","journal-title":"Biochim Biophys Acta"},{"key":"8358_CR53","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1242\/dev.008367","volume":"134","author":"MJ Potthoff","year":"2007","unstructured":"Potthoff MJ, Olson EN. MEF2: a central regulator of diverse developmental programs. Development. 2007;134:4131\u201340.","journal-title":"Development"},{"key":"8358_CR54","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.1093\/hmg\/ddu251","volume":"23","author":"Z Yao","year":"2014","unstructured":"Yao Z, Snider L, Balog J, Lemmers RJ, Van Der Maarel SM, Tawil R, et al. DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle. Hum Mol Genet. 2014;23:5342\u201352.","journal-title":"Hum Mol Genet"},{"key":"8358_CR55","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/rco2.67","volume":"5","author":"TG Francis","year":"2022","unstructured":"Francis TG, Jaka O, Ellison-Hughes GM, Lazarus NR, Harridge SDR. Human primary skeletal muscle-derived myoblasts and fibroblasts reveal different senescent phenotypes. JCSM Rapid Commun. 2022;5:226\u201338.","journal-title":"JCSM Rapid Commun"},{"key":"8358_CR56","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/mgg3.273","volume":"5","author":"LJ Gowans","year":"2017","unstructured":"Gowans LJ, Busch TD, Mossey PA, Eshete MA, Adeyemo WL, Aregbesola B, et al. The prevalence, penetrance, and expressivity of etiologic IRF6 variants in orofacial clefts patients from sub-Saharan Africa. Mol Genet Genom Med. 2017;5:164\u201371.","journal-title":"Mol Genet Genom Med"},{"key":"8358_CR57","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/22143602241289705","volume":"11","author":"G Halilo\u011flu","year":"2024","unstructured":"Halilo\u011flu G, Donkervoort S, Y\u0131ld\u0131z S\u00d6, Potticary A, Hu Y, Pais L, et al. Distinct whole-body muscle MRI imaging patterns in PAX7-congenital myopathy: A case report. J Neuromuscul Dis. 2024;11:1276\u201382.","journal-title":"J Neuromuscul Dis"},{"key":"8358_CR58","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13619-022-00116-9","volume":"11","author":"M Wang","year":"2022","unstructured":"Wang M, Li Z, Zhao S, Zheng Z, Wang Y, Qiu G, et al. The identification of PAX7 variants and a potential role of muscle development dysfunction in congenital scoliosis. Cell Regen. 2022;11:16.","journal-title":"Cell Regen"},{"key":"8358_CR59","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1002\/ajmg.a.36691","volume":"164A","author":"A Butali","year":"2014","unstructured":"Butali A, Mossey P, Adeyemo W, Eshete M, Gaines L, Braimah R, et al. Rare functional variants in genome-wide association identified candidate genes for nonsyndromic clefts in the African population. Am J Med Genet A. 2014;164A:2567\u201371.","journal-title":"Am J Med Genet A"},{"key":"8358_CR60","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/ajmg.a.35749","volume":"161A","author":"A Butali","year":"2013","unstructured":"Butali A, Suzuki S, Cooper ME, Mansilla AM, Cuenco K, Leslie EJ, et al. Replication of genome wide association identified candidate genes confirm the role of common and rare variants in PAX7 and VAX1 in the etiology of nonsyndromic CL(P). Am J Med Genet A. 2013;161A:965\u201372.","journal-title":"Am J Med Genet A"},{"key":"8358_CR61","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ajhg.2015.01.004","volume":"96","author":"EJ Leslie","year":"2015","unstructured":"Leslie EJ, Taub MA, Liu H, Steinberg KM, Koboldt DC, Zhang Q, et al. Identification of functional variants for cleft lip with or without cleft palate in or near PAX7, FGFR2, and NOG by targeted sequencing of GWAS loci. Am J Hum Genet. 2015;96:397\u2013411.","journal-title":"Am J Hum Genet"},{"key":"8358_CR62","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1111\/odi.13139","volume":"25","author":"A Gaczkowska","year":"2019","unstructured":"Gaczkowska A, Biedziak B, Budner M, Zadurska M, Lasota A, Hozyasz KK, et al. PAX7 nucleotide variants and the risk of non-syndromic orofacial clefts in the Polish population. Oral Dis. 2019;25:1608\u201318.","journal-title":"Oral Dis"},{"key":"8358_CR63","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/humu.23310","volume":"38","author":"R Proskorovski-Ohayon","year":"2017","unstructured":"Proskorovski-Ohayon R, Kadir R, Michalowski A, Flusser H, Perez Y, Hershkovitz E, et al. PAX7 mutation in a syndrome of failure to thrive, hypotonia, and global neurodevelopmental delay. Hum Mutat. 2017;38:1671\u201383.","journal-title":"Hum Mutat"},{"key":"8358_CR64","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1038\/emboj.2008.201","volume":"27","author":"D Bosnakovski","year":"2008","unstructured":"Bosnakovski D, Xu Z, Gang EJ, Galindo CL, Liu M, Simsek T, et al. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J. 2008;27:2766\u201379.","journal-title":"EMBO J"},{"key":"8358_CR65","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/hmg\/ddad175","volume":"33","author":"EN Engquist","year":"2024","unstructured":"Engquist EN, Greco A, Joosten LAB, van Engelen BGM, Zammit PS, Banerji CRS. FSHD muscle shows perturbation in fibroadipogenic progenitor cells, mitochondrial function and alternative splicing independently of inflammation. Hum Mol Genet. 2024;33:182\u201397.","journal-title":"Hum Mol Genet"},{"key":"8358_CR66","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s42003-024-06325-z","volume":"7","author":"T Schatzl","year":"2024","unstructured":"Schatzl T, Todorow V, Kaiser L, Weinschrott H, Schoser B, Deigner HP, et al. Meta-analysis towards FSHD reveals misregulation of neuromuscular junction, nuclear envelope, and spliceosome. Commun Biol. 2024;7:640.","journal-title":"Commun Biol"},{"key":"8358_CR67","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1002\/pmic.200600056","volume":"6","author":"B Celegato","year":"2006","unstructured":"Celegato B, Capitanio D, Pescatori M, Romualdi C, Pacchioni B, Cagnin S, et al. Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteomics. 2006;6:5303\u201321.","journal-title":"Proteomics"},{"key":"8358_CR68","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw7099","volume":"5","author":"AM DeSimone","year":"2019","unstructured":"DeSimone AM, Leszyk J, Wagner K, Emerson CP Jr. Identification of the hyaluronic acid pathway as a therapeutic target for facioscapulohumeral muscular dystrophy. Sci Adv. 2019;5:eaaw7099.","journal-title":"Sci Adv"},{"key":"8358_CR69","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.freeradbiomed.2016.08.007","volume":"99","author":"P Dmitriev","year":"2016","unstructured":"Dmitriev P, Bou Saada Y, Dib C, Ansseau E, Barat A, Hamade A, et al. DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients. Free Radic Biol Med. 2016;99:244\u201358.","journal-title":"Free Radic Biol Med"},{"key":"8358_CR70","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00109-004-0583-7","volume":"83","author":"D Laoudj-Chenivesse","year":"2005","unstructured":"Laoudj-Chenivesse D, Carnac G, Bisbal C, Hugon G, Bouillot S, Desnuelle C, et al. Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J Mol Med (Berl). 2005;83:216\u201324.","journal-title":"J Mol Med (Berl)"},{"key":"8358_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-4-67","volume":"4","author":"K Tsumagari","year":"2011","unstructured":"Tsumagari K, Chang SC, Lacey M, Baribault C, Chittur SV, Sowden J, et al. Gene expression during normal and FSHD myogenesis. BMC Med Genomics. 2011;4:67.","journal-title":"BMC Med Genomics"},{"key":"8358_CR72","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0960-8966(02)00284-5","volume":"13","author":"ST Winokur","year":"2003","unstructured":"Winokur ST, Barrett K, Martin JH, Forrester JR, Simon M, Tawil R, et al. Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul Disord. 2003;13:322\u201333.","journal-title":"Neuromuscul Disord"},{"key":"8358_CR73","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1093\/hmg\/ddg327","volume":"12","author":"ST Winokur","year":"2003","unstructured":"Winokur ST, Chen YW, Masny PS, Martin JH, Ehmsen JT, Tapscott SJ, et al. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet. 2003;12:2895\u2013907.","journal-title":"Hum Mol Genet"},{"key":"8358_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102251","volume":"51","author":"P Heher","year":"2022","unstructured":"Heher P, Ganassi M, Weidinger A, Engquist EN, Pruller J, Nguyen TH, et al. Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic target. Redox Biol. 2022;51:102251.","journal-title":"Redox Biol"},{"key":"8358_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102008","volume":"43","author":"A Karpukhina","year":"2021","unstructured":"Karpukhina A, Galkin I, Ma Y, Dib C, Zinovkin R, Pletjushkina O, et al. Analysis of genes regulated by DUX4 via oxidative stress reveals potential therapeutic targets for treatment of facioscapulohumeral dystrophy. Redox Biol. 2021;43:102008.","journal-title":"Redox Biol"},{"key":"8358_CR76","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1016\/j.cell.2025.03.008","volume":"188","author":"B Kalita","year":"2025","unstructured":"Kalita B, Martinez-Cebrian G, McEvoy J, Allensworth M, Knight M, Magli A, et al. PAX translocations remodel mitochondrial metabolism through altered leucine usage in rhabdomyosarcoma. Cell. 2025;188:2757\u201377e22.","journal-title":"Cell"},{"key":"8358_CR77","doi-asserted-by":"publisher","first-page":"e0146893","DOI":"10.1371\/journal.pone.0146893","volume":"11","author":"E Ansseau","year":"2016","unstructured":"Ansseau E, Eidahl JO, Lancelot C, Tassin A, Matteotti C, Yip C, et al. Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation. PLoS One. 2016;11:e0146893.","journal-title":"PLoS One"},{"key":"8358_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.943032","volume":"12","author":"K Xu","year":"2022","unstructured":"Xu K, Sun S, Yan M, Cui J, Yang Y, Li W, et al. DDX5 and DDX17-multifaceted proteins in the regulation of tumorigenesis and tumor progression. Front Oncol. 2022;12:943032.","journal-title":"Front Oncol"},{"key":"8358_CR79","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41392-024-01831-2","volume":"9","author":"M Yan","year":"2024","unstructured":"Yan M, Gao J, Lan M, Wang Q, Cao Y, Zheng Y, et al. DEAD-box helicase 17 (DDX17) protects cardiac function by promoting mitochondrial homeostasis in heart failure. Signal Transduct Target Ther. 2024;9:127.","journal-title":"Signal Transduct Target Ther"},{"key":"8358_CR80","doi-asserted-by":"publisher","first-page":"613","DOI":"10.5483\/BMBRep.2018.51.12.234","volume":"51","author":"G Giraud","year":"2018","unstructured":"Giraud G, Terrone S, Bourgeois CF. Functions of DEAD box RNA helicases DDX5 and DDX17 in chromatin organization and transcriptional regulation. BMB Rep. 2018;51:613\u201322.","journal-title":"BMB Rep"},{"key":"8358_CR81","doi-asserted-by":"publisher","first-page":"e7482","DOI":"10.1371\/journal.pone.0007482","volume":"4","author":"E Ansseau","year":"2009","unstructured":"Ansseau E, Laoudj-Chenivesse D, Marcowycz A, Tassin A, Vanderplanck C, Sauvage S, et al. DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS One. 2009;4:e7482.","journal-title":"PLoS One"},{"key":"8358_CR82","first-page":"223","volume":"2","author":"R Janknecht","year":"2010","unstructured":"Janknecht R. Multi-talented DEAD-box proteins and potential tumor promoters: p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase (DDX17). Am J Transl Res. 2010;2:223\u201334.","journal-title":"Am J Transl Res"},{"key":"8358_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109910","volume":"37","author":"J Cao","year":"2021","unstructured":"Cao J, Verma SK, Jaworski E, Mohan S, Nagasawa CK, Rayavara K, et al. RBFOX2 is critical for maintaining alternative polyadenylation patterns and mitochondrial health in rat myoblasts. Cell Rep. 2021;37:109910.","journal-title":"Cell Rep"},{"key":"8358_CR84","doi-asserted-by":"crossref","unstructured":"Vecellio Reane D, Cerqua C, Sacconi S, Salviati L, Trevisson E, Raffaello A. The splicing of the mitochondrial calcium uniporter genuine activator MICU1 is driven by RBFOX2 splicing factor during myogenic differentiation. Int J Mol Sci. 2022;23:2517.","DOI":"10.3390\/ijms23052517"},{"key":"8358_CR85","doi-asserted-by":"crossref","unstructured":"Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, McDermott MG, et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database (Oxford). 2016;2016:baw100.","DOI":"10.1093\/database\/baw100"},{"key":"8358_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103097","volume":"24","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wang Z, Xu Q, Chen Y, Liu W, Zhong T, et al. Splicing factor Srsf5 deletion disrupts alternative splicing and causes noncompaction of ventricular myocardium. iScience. 2021;24:103097.","journal-title":"iScience"},{"key":"8358_CR87","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1093\/nar\/gkw141","volume":"44","author":"SH Choi","year":"2016","unstructured":"Choi SH, Gearhart MD, Cui Z, Bosnakovski D, Kim M, Schennum N, et al. DUX4 recruits p300\/CBP through its C-terminus and induces global H3K27 acetylation changes. Nucleic Acids Res. 2016;44:5161\u201373.","journal-title":"Nucleic Acids Res"},{"key":"8358_CR88","doi-asserted-by":"publisher","first-page":"8492","DOI":"10.1074\/jbc.273.14.8492","volume":"273","author":"M Ichida","year":"1998","unstructured":"Ichida M, Endo H, Ikeda U, Matsuda C, Ueno E, Shimada K, et al. MyoD is indispensable for muscle-specific alternative splicing in mouse mitochondrial ATP synthase gamma-subunit pre-mRNA. J Biol Chem. 1998;273:8492\u2013501.","journal-title":"J Biol Chem"},{"key":"8358_CR89","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.celrep.2016.09.010","volume":"17","author":"J Shintaku","year":"2016","unstructured":"Shintaku J, Peterson JM, Talbert EE, Gu JM, Ladner KJ, Williams DR, et al. MyoD Regulates Skeletal Muscle Oxidative Metabolism Cooperatively with Alternative NF-kappaB. Cell Rep. 2016;17:514\u201326.","journal-title":"Cell Rep"},{"key":"8358_CR90","first-page":"3579","volume":"9","author":"F Martelli","year":"1994","unstructured":"Martelli F, Cenciarelli C, Santarelli G, Polikar B, Felsani A, Caruso M. MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene. 1994;9:3579\u201390.","journal-title":"Oncogene"},{"key":"8358_CR91","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1242\/jcs.112.17.2895","volume":"112","author":"RN Cooper","year":"1999","unstructured":"Cooper RN, Tajbakhsh S, Mouly V, Cossu G, Buckingham M, Butler-Browne GS. In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J Cell Sci. 1999;112:2895\u2013901.","journal-title":"J Cell Sci"},{"key":"8358_CR92","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/cge.14533","volume":"106","author":"E Giardina","year":"2024","unstructured":"Giardina E, Camano P, Burton-Jones S, Ravenscroft G, Henning F, Magdinier F, et al. Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy: Update of the 2012 guidelines. Clin Genet. 2024;106:13\u201326.","journal-title":"Clin Genet"},{"key":"8358_CR93","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10048-019-00575-4","volume":"20","author":"S Zampatti","year":"2019","unstructured":"Zampatti S, Colantoni L, Strafella C, Galota RM, Caputo V, Campoli G, et al. Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era. Neurogenetics. 2019;20:57\u201364.","journal-title":"Neurogenetics"},{"key":"8358_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01747-2","volume":"16","author":"C Strafella","year":"2024","unstructured":"Strafella C, Megalizzi D, Trastulli G, Proietti Piorgo E, Colantoni L, Tasca G, et al. Integrating D4Z4 methylation analysis into clinical practice: improvement of FSHD molecular diagnosis through distinct thresholds for 4qA\/4qA and 4qA\/4qB patients. Clin Epigenetics. 2024;16:148.","journal-title":"Clin Epigenetics"},{"key":"8358_CR95","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/pro.3746","volume":"29","author":"RA Laskowski","year":"2020","unstructured":"Laskowski RA, Stephenson JD, Sillitoe I, Orengo CA, Thornton JM. VarSite: Disease variants and protein structure. Protein Sci. 2020;29:111\u20139.","journal-title":"Protein Sci"},{"key":"8358_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1235589","volume":"14","author":"C Strafella","year":"2023","unstructured":"Strafella C, Caputo V, Bortolani S, Torchia E, Megalizzi D, Trastulli G, et al. Whole exome sequencing highlights rare variants in CTCF, DNMT1, DNMT3A, EZH2 and SUV39H1 as associated with FSHD. Front Genet. 2023;14:1235589.","journal-title":"Front Genet"},{"key":"8358_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-1-34","volume":"1","author":"K Mamchaoui","year":"2011","unstructured":"Mamchaoui K, Trollet C, Bigot A, Negroni E, Chaouch S, Wolff A, et al. Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders. Skelet Muscle. 2011;1:34.","journal-title":"Skelet Muscle"},{"key":"8358_CR98","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12717","volume":"53","author":"N Figeac","year":"2020","unstructured":"Figeac N, Pruller J, Hofer I, Fortier M, Ortuste Quiroga HP, Banerji CRS, et al. DEPDC1B is a key regulator of myoblast proliferation in mouse and man. Cell Prolif. 2020;53:e12717.","journal-title":"Cell Prolif"},{"key":"8358_CR99","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41417-020-00225-0","volume":"28","author":"J Pruller","year":"2021","unstructured":"Pruller J, Hofer I, Ganassi M, Heher P, Ma MT, Zammit PS. A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy. Cancer Gene Ther. 2021;28:427\u201341.","journal-title":"Cancer Gene Ther"},{"key":"8358_CR100","doi-asserted-by":"crossref","unstructured":"Ortuste Quiroga HP, Ganassi M, Yokoyama S, Nakamura K, Yamashita T, Raimbach D, et al. Fine-tuning of piezo1 expression and activity ensures efficient myoblast fusion during skeletal myogenesis. Cells. 2022;11:393.","DOI":"10.3390\/cells11030393"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08358-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08358-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08358-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T15:03:16Z","timestamp":1770303796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08358-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8358"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08358-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declared no competing of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. This study was approved by the Ethical Committee of the Helsinki University Hospital (HUS\/16896\/2022) and Ethics Committee of Santa Lucia Foundation IRCCS (CE\/2022_020 approved on June 1, 2022). Written informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"179"}}